Life Sciences and AI: A Powerful Partnership for a Resilient Tomorrow
With data being the critical ingredient in driving innovation, businesses must address data privacy to prevent erosion of trust in brands and reluctance of customers to share data.
The customer experience imperative: How lifesciences companies can win
Lifesciences companies need to invest in digital technology to improve customer experience (CX). When understood and implemented properly, lifesciences companies can better understand and map the patient journey leading to more interactions along the value chain leading to increased sales volumes.
Marlabs Brazil- How Technology Powered 360 Suites Expansion from 4 to 2000 Apartments
Get an insider look at how Marlabs helped 360 Suites leverage cutting-edge technology to transform their business, boosting their revenue in the process. Hear from Debora Beda, Founder and CEO of 360 Suites, as she shares her story of embracing innovation and achieving remarkable results.
Rise of AI in pharma
Pharmaceutical companies are able to make informed decisions, optimize their research and development efforts, and bring safe and effective treatments to patients faster than ever before due to AI’s ability
Harnessing generative AI to enhance rare disease awareness
We explore the challenges posed by rare diseases, the critical importance of timely diagnosis, and how generative AI enhances awareness and treatment.
Reinventing the contact center and helping healthcare payer build stability, resilience, and future readiness
In an increasingly competitive and digitally driven world, organizations must ensure that their customer engagement channels are resilient, efficient, and responsive.
Propelling a global life sciences corporation into the digital future
The present case study delves into the collaborative journey of Marlabs, a premier digital solutions provider and a global life sciences company. By examining the numerous challenges faced by the organization and Marlabs
Unleashing the power of digital transformation to accelerate covid-19 test kit production
The COVID-19 pandemic created an unprecedented global demand for diagnostic test kits, putting immense pressure on pharmaceutical companies to scale production.
Hybrid intelligence for pre-emptive medical care
Kamran Khan’s Canadian AI start-up BlueDot was the first to identify an unusual flu at the market in Wuhan, China, in late 2019. This was nine days before the World Health Organization (WHO) released its official statement on COVID-19.
Optimizing customer experience in lifesciences through omnichannel commerce
Life sciences companies are particularly well suited to benefit from the omni-channel strategy because it provides them with valuable opportunities to collect and analyze valuable information and data.